1. 206PProtroca: A non-interventional study on prophylaxis of chemotherapy induced neutropenia using lipegfilgrastim in non-selected breast cancer patients. (13th May 2019) Authors: Wuerstlein, R; Harbeck, N; Grischke, E-M; Forstmeyer, D; von Schumann, R; Krabisch, P; Nitz, U; Gluz, O; Kates, R E; Graeser, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial. (24th October 2017) Authors: Möbus, V; Jackisch, C; Lück, H J; du Bois, A; Thomssen, C; Kuhn, W; Nitz, U; Schneeweiss, A; Huober, J; Harbeck, N; von Minckwitz, G; Runnebaum, I B; Hinke, A; Konecny, G E; Untch, M; Kurbacher, C Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA13Prognostic impact of anthracyclines and immune/proliferation markers in TNBC according to pCR after de-escalated neoadjuvant chemotherapy with 12 weeks of nab-paclitaxel/carboplatin or gemcitabine: Survival results of WSG-ADAPT-TN phase II trial. (23rd October 2018) Authors: Gluz, O; Nitz, U; Liedtke, C; Christgen, M; Grischke, E-M; Forstbauer, H; Braun, M; Warm, M; Hackmann, J; Uleer, C; Aktas, B; Schumacher, C; Lindner, C; Kümmel, S; Kates, R E; Potenberg, J; Staib, P; Wuerstlein, R; Kreipe, H H; Harbeck, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗